BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19828471)

  • 1. Human IgG antibody profiles differentiate between symptomatic patients with and without colorectal cancer.
    Kijanka G; Hector S; Kay EW; Murray F; Cummins R; Murphy D; MacCraith BD; Prehn JH; Kenny D
    Gut; 2010 Jan; 59(1):69-78. PubMed ID: 19828471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A plasma microRNA panel for early detection of colorectal cancer.
    Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
    Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification.
    DePrimo SE; Wong LM; Khatry DB; Nicholas SL; Manning WC; Smolich BD; O'Farrell AM; Cherrington JM
    BMC Cancer; 2003 Feb; 3():3. PubMed ID: 12657164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer.
    Van Beijnum JR; Moerkerk PT; Gerbers AJ; De Bruïne AP; Arends JW; Hoogenboom HR; Hufton SE
    Int J Cancer; 2002 Sep; 101(2):118-27. PubMed ID: 12209988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa.
    Bianchini M; Levy E; Zucchini C; Pinski V; Macagno C; De Sanctis P; Valvassori L; Carinci P; Mordoh J
    Int J Oncol; 2006 Jul; 29(1):83-94. PubMed ID: 16773188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A microRNA panel to discriminate carcinomas from high-grade intraepithelial neoplasms in colonoscopy biopsy tissue.
    Wang S; Wang L; Bayaxi N; Li J; Verhaegh W; Janevski A; Varadan V; Ren Y; Merkle D; Meng X; Gao X; Wang H; Ren J; Kuo WP; Dimitrova N; Wu Y; Zhu H
    Gut; 2013 Feb; 62(2):280-9. PubMed ID: 22535378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative transcriptome maps: a new approach to the diagnosis of colorectal carcinoma patients using cDNA microarrays.
    Jansová E; Koutná I; Krontorád P; Svoboda Z; Krivánková S; Zaloudík J; Kozubek M; Kozubek S
    Clin Genet; 2006 Mar; 69(3):218-27. PubMed ID: 16542386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infrequent and low expression of cancer-testis antigens located on the X chromosome in colorectal cancer: implications for immunotherapy in South African populations.
    Dakshinamurthy AG; Ramesar R; Goldberg P; Blackburn JM
    Biotechnol J; 2008 Nov; 3(11):1417-23. PubMed ID: 18956367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMP3 and CXCL1 are potent stromal protein markers of dysplasia-carcinoma transition in sporadic colorectal cancer.
    Sipos F; Germann TM; Wichmann B; Galamb O; Spisák S; Krenács T; Tulassay Z; Molnár B; Műzes G
    Eur J Cancer Prev; 2014 Sep; 23(5):336-43. PubMed ID: 24999605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer.
    Mischo A; Kubuschok B; Ertan K; Preuss KD; Romeike B; Regitz E; Schormann C; de Bruijn D; Wadle A; Neumann F; Schmidt W; Renner C; Pfreundschuh M
    Int J Cancer; 2006 Feb; 118(3):696-703. PubMed ID: 16094643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of TROP2 expression in colorectal cancer.
    Ohmachi T; Tanaka F; Mimori K; Inoue H; Yanaga K; Mori M
    Clin Cancer Res; 2006 May; 12(10):3057-63. PubMed ID: 16707602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of colonoscopy on whole blood gene expression profile: an experimental investigation for colorectal cancer biomarker discovery.
    Xu Y; Xu Q; Yang L; Liu F; Ye X; Wu F; Ni S; Tan C; Cai G; Meng X; Cai S; Du X
    J Cancer Res Clin Oncol; 2015 Apr; 141(4):591-9. PubMed ID: 25306939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets.
    Scanlan MJ; Welt S; Gordon CM; Chen YT; Gure AO; Stockert E; Jungbluth AA; Ritter G; Jäger D; Jäger E; Knuth A; Old LJ
    Cancer Res; 2002 Jul; 62(14):4041-7. PubMed ID: 12124339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
    Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
    Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein macroarray profiling of serum autoantibodies in pseudoexfoliation glaucoma.
    Dervan EW; Chen H; Ho SL; Brummel N; Schmid J; Toomey D; Haralambova M; Gould E; Wallace DM; Prehn JH; O'Brien CJ; Murphy D
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):2968-75. PubMed ID: 20107165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies against the tumour-associated antigen GA733-2 in patients with colorectal carcinoma.
    Mosolits S; Harmenberg U; Rudén U; Ohman L; Nilsson B; Wahren B; Fagerberg J; Mellstedt H
    Cancer Immunol Immunother; 1999 Feb; 47(6):315-20. PubMed ID: 10203061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple serological biomarkers for colorectal cancer detection.
    Chan CC; Fan CW; Kuo YB; Chen YH; Chang PY; Chen KT; Hung RP; Chan EC
    Int J Cancer; 2010 Apr; 126(7):1683-90. PubMed ID: 19795454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel, quantitative protein microarray platform for the multiplexed serological analysis of autoantibodies to cancer-testis antigens.
    Beeton-Kempen N; Duarte J; Shoko A; Serufuri JM; John T; Cebon J; Blackburn J
    Int J Cancer; 2014 Oct; 135(8):1842-51. PubMed ID: 24604332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
    Knychalski B; Lukieńczuk T
    Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients.
    Ueda R; Yoshida K; Kawase T; Kawakami Y; Toda M
    Int J Cancer; 2007 Apr; 120(8):1704-11. PubMed ID: 17230535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.